Compare Elder Pharma with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs WOCKHARDT - Comparison Results

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA WOCKHARDT ELDER PHARMA/
WOCKHARDT
 
P/E (TTM) x -0.2 -23.0 - View Chart
P/BV x 0.1 1.2 8.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   WOCKHARDT
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
WOCKHARDT
Mar-18
ELDER PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs3801,012 37.5%   
Low Rs188532 35.4%   
Sales per share (Unadj.) Rs491.2355.9 138.0%  
Earnings per share (Unadj.) Rs-3.2-60.3 5.3%  
Cash flow per share (Unadj.) Rs14.4-46.8 -30.8%  
Dividends per share (Unadj.) Rs00.01 0.0%  
Dividend yield (eoy) %00 0.0%  
Book value per share (Unadj.) Rs376.5257.8 146.0%  
Shares outstanding (eoy) m20.54110.63 18.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.2 26.7%   
Avg P/E ratio x-89.3-12.8 697.2%  
P/CF ratio (eoy) x19.7-16.5 -119.4%  
Price / Book Value ratio x0.83.0 25.2%  
Dividend payout %00 0.0%   
Avg Mkt Cap Rs m5,83385,379 6.8%   
No. of employees `000NA6.3 0.0%   
Total wages/salary Rs m2,1799,371 23.3%   
Avg. sales/employee Rs ThNM6,295.0-  
Avg. wages/employee Rs ThNM1,498.3-  
Avg. net profit/employee Rs ThNM-1,066.3-  
INCOME DATA
Net Sales Rs m10,08939,369 25.6%  
Other income Rs m2571,202 21.3%   
Total revenues Rs m10,34640,571 25.5%   
Gross profit Rs m-79218 -4,327.3%  
Depreciation Rs m3611,495 24.2%   
Interest Rs m2,7562,555 107.9%   
Profit before tax Rs m-3,653-2,830 129.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-3,582 -103.7%   
Tax Rs m125257 48.7%   
Profit after tax Rs m-65-6,669 1.0%  
Gross profit margin %-7.80 -16,885.8%  
Effective tax rate %-3.4-9.1 37.7%   
Net profit margin %-0.6-16.9 3.8%  
BALANCE SHEET DATA
Current assets Rs m9,24033,796 27.3%   
Current liabilities Rs m9,99826,917 37.1%   
Net working cap to sales %-7.517.5 -43.0%  
Current ratio x0.91.3 73.6%  
Inventory Days Days4679 58.4%  
Debtors Days Days6089 67.2%  
Net fixed assets Rs m10,12439,664 25.5%   
Share capital Rs m206553 37.2%   
"Free" reserves Rs m5,58227,968 20.0%   
Net worth Rs m7,73428,522 27.1%   
Long term debt Rs m4,88921,731 22.5%   
Total assets Rs m22,88281,620 28.0%  
Interest coverage x-0.3-0.1 302.5%   
Debt to equity ratio x0.60.8 83.0%  
Sales to assets ratio x0.40.5 91.4%   
Return on assets %11.8-5.0 -233.3%  
Return on equity %-0.8-23.4 3.6%  
Return on capital %22.3-7.7 -290.7%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m3079,807 3.1%   
Fx outflow Rs m1251,789 7.0%   
Net fx Rs m1818,019 2.3%   
CASH FLOW
From Operations Rs m11,754684 1,717.4%  
From Investments Rs m-5616,302 -8.9%  
From Financial Activity Rs m-6,762-7,695 87.9%  
Net Cashflow Rs m4,432-664 -667.4%  

Share Holding

Indian Promoters % 39.6 74.5 53.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 2.3 326.1%  
FIIs % 16.8 7.7 218.2%  
ADR/GDR % 0.0 0.1 -  
Free float % 36.1 15.4 234.4%  
Shareholders   16,479 67,757 24.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  FULFORD INDIA  JUBILANT LIFE SCIENCES  BIOCON   

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS